David A. Frank
Department of Adult Oncology
Dana-Farber Cancer Institute
Boston
Massachusetts 02115
USA
Name/email consistency: high
- Targeting transcription factors for cancer therapy. Frank, D.A. IDrugs (2009)
- STAT3 as a central mediator of neoplastic cellular transformation. Frank, D.A. Cancer Lett. (2007)
- The treatment and outcome of cancer patients with thromboses on central venous catheters. Frank, D.A., Meuse, J., Hirsch, D., Ibrahim, J.G., van den Abbeele, A.D. J. Thromb. Thrombolysis (2000)
- Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling. Frank, D.A., Mahajan, S., Ritz, J. Nat. Med. (1999)
- STAT signaling in the pathogenesis and treatment of cancer. Frank, D.A. Mol. Med. (1999)
- B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues. Frank, D.A., Mahajan, S., Ritz, J. J. Clin. Invest. (1997)